Cargando…
481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022
BACKGROUND: National surveillance can provide insights into trends in pediatric SARS-CoV-2-related hospitalizations during the pandemic and healthcare-associated infections. [Figure: see text] METHODS: From March 1, 2020, to December 31, 2022, the Canadian Nosocomial Infection Surveillance Program c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677607/ http://dx.doi.org/10.1093/ofid/ofad500.551 |
_version_ | 1785150169628540928 |
---|---|
author | Lee, Diane Mitchell, Robyn Pelude, Linda Frenette, Charles Lee, Bonita Lefebvre, Marie-Astrid Comeau, Jeannette L Srigley, Jocelyn Thampi, Nisha |
author_facet | Lee, Diane Mitchell, Robyn Pelude, Linda Frenette, Charles Lee, Bonita Lefebvre, Marie-Astrid Comeau, Jeannette L Srigley, Jocelyn Thampi, Nisha |
author_sort | Lee, Diane |
collection | PubMed |
description | BACKGROUND: National surveillance can provide insights into trends in pediatric SARS-CoV-2-related hospitalizations during the pandemic and healthcare-associated infections. [Figure: see text] METHODS: From March 1, 2020, to December 31, 2022, the Canadian Nosocomial Infection Surveillance Program collected patient-level data on pediatric patients (under age 18 years) hospitalized with laboratory-confirmed SARS-CoV-2 from 9 pediatric and 25 mixed adult-pediatric hospitals. Pediatric COVID-19 vaccines became available for 12-17 years in May 2021 and for 5-11 years in November 2021. RESULTS: Of 4,878 pediatric patients, most (80.3%) were hospitalized with SARS-CoV-2 infection during the Omicron-dominant period (since Jan 2022); a higher proportion involved patients under five years of age (58.5% vs 46.9%, p < 0.001). Most hospitalizations pre-Omicron involved children not vaccinated against COVID-19 (92%) versus 70% during Omicron (p < 0.001). However, a lower proportion required intensive care during Omicron (15% vs 20%, p < 0.001). There was no difference in pre-existing comorbidities or mortality between periods. Overall, there were 257 healthcare-associated COVID-19 infections (HA-COVID) reported (5.4%); 89% occurred during Omicron. While there was no difference in median ages of patients with HA-COVID and community-associated COVID-19 infections (CA-COVID), 62% of patients with HA-COVID had a pre-existing comorbidity compared to 44% with CA-COVID (p < 0.001), and 24% remained in hospital at 30 days after HA-COVID, compared to 2.2% with CA-COVID (p < 0.001). Nearly 50% of patients with HA-COVID had received at least one vaccine dose, compared to 25% with CA-COVID. CONCLUSION: During the Omicron-dominant period, a higher proportion of admitted patients with SARS-CoV-2 infection were under five years, but a lower proportion were unvaccinated and a lower proportion required intensive care and mortality was comparable between both periods. Only 5.4% of pediatric COVID-related hospitalizations were HAI, with most during Omicron. Patients with HAI were more likely to have a pre-existing comorbidity and increased hospital stay, potentially related to their underlying conditions. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10677607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106776072023-11-27 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 Lee, Diane Mitchell, Robyn Pelude, Linda Frenette, Charles Lee, Bonita Lefebvre, Marie-Astrid Comeau, Jeannette L Srigley, Jocelyn Thampi, Nisha Open Forum Infect Dis Abstract BACKGROUND: National surveillance can provide insights into trends in pediatric SARS-CoV-2-related hospitalizations during the pandemic and healthcare-associated infections. [Figure: see text] METHODS: From March 1, 2020, to December 31, 2022, the Canadian Nosocomial Infection Surveillance Program collected patient-level data on pediatric patients (under age 18 years) hospitalized with laboratory-confirmed SARS-CoV-2 from 9 pediatric and 25 mixed adult-pediatric hospitals. Pediatric COVID-19 vaccines became available for 12-17 years in May 2021 and for 5-11 years in November 2021. RESULTS: Of 4,878 pediatric patients, most (80.3%) were hospitalized with SARS-CoV-2 infection during the Omicron-dominant period (since Jan 2022); a higher proportion involved patients under five years of age (58.5% vs 46.9%, p < 0.001). Most hospitalizations pre-Omicron involved children not vaccinated against COVID-19 (92%) versus 70% during Omicron (p < 0.001). However, a lower proportion required intensive care during Omicron (15% vs 20%, p < 0.001). There was no difference in pre-existing comorbidities or mortality between periods. Overall, there were 257 healthcare-associated COVID-19 infections (HA-COVID) reported (5.4%); 89% occurred during Omicron. While there was no difference in median ages of patients with HA-COVID and community-associated COVID-19 infections (CA-COVID), 62% of patients with HA-COVID had a pre-existing comorbidity compared to 44% with CA-COVID (p < 0.001), and 24% remained in hospital at 30 days after HA-COVID, compared to 2.2% with CA-COVID (p < 0.001). Nearly 50% of patients with HA-COVID had received at least one vaccine dose, compared to 25% with CA-COVID. CONCLUSION: During the Omicron-dominant period, a higher proportion of admitted patients with SARS-CoV-2 infection were under five years, but a lower proportion were unvaccinated and a lower proportion required intensive care and mortality was comparable between both periods. Only 5.4% of pediatric COVID-related hospitalizations were HAI, with most during Omicron. Patients with HAI were more likely to have a pre-existing comorbidity and increased hospital stay, potentially related to their underlying conditions. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677607/ http://dx.doi.org/10.1093/ofid/ofad500.551 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Lee, Diane Mitchell, Robyn Pelude, Linda Frenette, Charles Lee, Bonita Lefebvre, Marie-Astrid Comeau, Jeannette L Srigley, Jocelyn Thampi, Nisha 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title | 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title_full | 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title_fullStr | 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title_full_unstemmed | 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title_short | 481. Trends in SARS-CoV-2-related Pediatric Hospitalizations in the Canadian Nosocomial Infection Surveillance Program, March 2020 to December 2022 |
title_sort | 481. trends in sars-cov-2-related pediatric hospitalizations in the canadian nosocomial infection surveillance program, march 2020 to december 2022 |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677607/ http://dx.doi.org/10.1093/ofid/ofad500.551 |
work_keys_str_mv | AT leediane 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT mitchellrobyn 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT peludelinda 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT frenettecharles 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT leebonita 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT lefebvremarieastrid 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT comeaujeannettel 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT srigleyjocelyn 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 AT thampinisha 481trendsinsarscov2relatedpediatrichospitalizationsinthecanadiannosocomialinfectionsurveillanceprogrammarch2020todecember2022 |